Neuromod Devices Ltd., an Ireland-based global medical technology business that says it created the first and only FDA Approved tinnitus treatment device, Lenire, announced on Wednesday that it has named Tom Maher as its new general counsel, effective 5 July 2024.

In the new role, Maher will be responsible for legal and contractual affairs, corporate transactions, governance, and corporate compliance for the company.

Most recently, Maher held the position of chief of operations, corporate counsel and company secretary for Amarin Pharmaceuticals Ireland. He has a successful track record in three C-Suite positions for publicly traded companies. He has over 25 years of corporate legal and business experience in the international life sciences industry, including biopharma, biotech, and medtech.